Overview / Abstract: |
Target Audience Program Overview Learning Objectives Personalize the selection of therapies for the management of cardiovascular and renal risk in patients with T2DM based on up-to-date standards of care |
Expiration |
Dec 03, 2021 |
Discipline(s) |
Physician CME |
Format |
Online |
Credits / Hours |
2.0 |
Accreditation |
ACCME, ANCC |
Presenters / Authors / Faculty |
Silvio E. Inzucchi, MD |
Sponsors / Supporters / Grant Providers |
Lilly, Boehringer Ingelheim Pharmaceuticals, and Merck & Co., Inc. |
Keywords / Search Terms |
Relias LLC Relias, free CME, diabetes Free CE CME |